Drotaverine is a drug belonging to the class of spasmolytic antispasmodics. This drug is mainly used to treat abdominal cramps, colic pain, stomachache, menstrual pain and works by relaxing the muscles of the digestive tract and is widely used in adults, pediatric and elderly patients.
Drotaverine is used for the symptomatic treatment of abdominal pain which is caused by gastrointestinal spasms and cramping. It is also used to treat conditions such as stomach ulcer, colic pain in infants, renal colic, biliary colic and gall bladder pain.
Drotaverine is a spasmolytic antispasmodic drug which works by relaxating the smooth muscles of the wall of the digestive tract. It mainly works on the anticholinergic receptors, calcium channels and constrictor mediators present on the gut wall.
Drotaverine takes around 15-30 minutes to take effect in relieving abdominal cramps and other associated pains. It can act as a fast-acting pain reliever and produce almost instant relief.
Drotaverine is well-absorbed in the gastrointestinal tract and reaches its peak plasma concentration within 1-2 hours after oral administration.
Drotaverine is mainly eliminated through the kidneys via urine in an unchanged form. It's elimination half-life is around 2 to 2.5 hours.
The dose of Drotaverine depends on the condition being treated and may vary for each individual patient. The usual dose for adults is 40 - 80mg 3-4 times a day while the usual dose for pediatric patients is 0.2 - 0.4mg per kg body weight 3-4 times a day. This drug must be taken by mouth with a full glass of water or as per the directions of a doctor.
Drotaverine is available in tablet form and is best taken one hour before or two hours after meals. It is important that this medicine should be taken regularly as prescribed for optimal effect.
Drotaverine has low toxicity in humans and is only associated with mild to moderate side effects when taken in high doses.
Drotaverine may interact with other medications such as anticoagulants, anticholinergic drugs, antihistamines, tricyclic antidepressants and diuretics.
Drotaverine may interact with certain medical conditions such as hepatic cirrhosis, prostatic hypertrophy, pyloric stenosis, hepatic impairment, hyperthyroidism, and Parkinson’s Disease.
Drotaverine may interact with certain drugs such as barbiturates, narcotics, benzodiazepines, anticholinergics, phenothiazines, and MAOIs (monoamine oxidase inhibitors).
Drotaverine should not be taken with high-fat foods as it can reduce its absorption.
Drotaverine should be used with caution in pregnant women. It is recommended to take this medicine only if clearly needed during pregnancy.
Drotaverine can pass through breast milk and can harm an infant. Therefore, it is not recommended to take it during lactation.
Symptoms of overdose include dizziness, drowsiness, confusion, nausea, vomiting and stomach pain. Seek immediate medical attention in case of an overdose.
Drotaverine is contraindicated in patients with hypersensitivity and severe gastrointestinal obstruction.
Drotaverine should be stored at room temperature in an airtight container away from direct light and moisture.
The volume of distribution of Drotaverine is approximately 42 L/kg.
The half-life of Drotaverine is approximately 2-2.5 hours.
The hepatic clearance of Drotaverine is approximately 2.3 L/h/kg.
See in details version Drotaverine also Drotaverine in bangla